When someone undergoes a major joint replacement, like a new hip or knee, one of the biggest fears is a deep infection. These infections are serious and can lead to failed surgeries. Researchers looked at data from over 6,000 cases to see if delivering an antibiotic called vancomycin directly into the bone (intraosseous) works better than standard intravenous methods.
The results showed that patients who received the medicine in their bone had much higher concentrations of the drug in both bone and fat tissue. This method significantly reduced overall infection rates and specific gram-positive infections in primary knee replacements. It also led to fewer wound complications for patients undergoing both initial surgeries and revision procedures.
Importantly, this targeted delivery did not increase risks for serious side effects like kidney issues or blood clots. While the study found no significant difference in preventing gram-negative infections, it suggests that local delivery is a safer way to keep antibiotic levels high where they are needed most. Talk to your surgeon about these options if you are planning a joint replacement.
